newsfilter
← Latest News
GlobeNewswire·

Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

  • Mineralys Therapeutics (Nasdaq: MLYS) granted inducement equity awards on November 3, 2026, to a new non-executive employee under Nasdaq Listing Rule 5635(c)(4).
  • The award package consists of 14,880 inducement stock options & 11,160 inducement restricted stock units (RSUs) of Mineralys common stock.
  • The stock options vest over four years starting November 2, 2026, with 25% vesting on the first anniversary & 1/48th monthly thereafter.
  • The RSUs vest over four years starting November 2, 2026, with 25% vesting on each of the first four anniversaries.
  • Both awards were granted under Mineralys' 2025 Employment Inducement Incentive Award Plan & are subject to continued service.
Company
Mineralys Therapeutics, Inc.
Keywords
Nasdaq:MLYS, Mineralys Therapeutics, Inc.